Status:
COMPLETED
Difference in Central Fatigue During Two Ultra-endurance Practices: Running vs. Cycling
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Ultra-marathon Runners
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The mechanisms contributing to muscle fatigue in extreme long-duration exercise bouts are poorly understood. Ultra-endurance exercise is an excellent model for the study of adaptive responses to extre...
Eligibility Criteria
Inclusion
- Specialist in endurance and ultra-endurance. in the 2 disciplines: running and cycling (triathletes, duathletes or trailers achieving at least 30% of their training volume in cycling), and having at least finished one long distance event in the last 2 years,
- Affiliated or beneficiary of a social security scheme.
- Signature of the consent form
Exclusion
- Any subject who has been injured in the 3 months prior to the protocol
- Anyone with chronic joint pathologies (e.g.: repetitive sprains, patellar or ligament problems).
- Any subject with chronic or central neurological pathologies
- Any subject with a contraindication to magnetic stimulation
- Use of neuro-active substances likely to alter cortico-spinal excitability (hypnotics, antiepileptics, psychotropic drugs, muscle relaxants) on the study.
- Contraindication to the application of a magnetic field:
- Heart or respiratory insufficiency.
- Subject with a cardiac pace maker.
- Cardiac valve wear and serious cardiovascular diseases.
- Presence of prosthetic material or ferromagnetic foreign bodies in the head.
- Presence of cochlear implants or ocular prosthetic material.
- History of neurosurgical interventions.
- Neurological diseases that may affect brain structures and cognitive abilities (e.g., intracranial tumour, multiple sclerosis, history of stroke or traumatic brain injury).
- History of comitiality, contralateral knee disease or musculoskeletal disease.
- Any subject participating at the same time in another interventional experiment requiring physical exercise.
- Any subject who has taken corticosteroids within 3 months (inhalation, infiltration or history of prolonged corticosteroid therapy).
- Any subject under guardianship or curatorship
Key Trial Info
Start Date :
March 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2021
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04511858
Start Date
March 5 2021
End Date
July 15 2021
Last Update
November 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Saint-Etienne
Saint-Etienne, France, 42000